- Home
- ยป
- Our Products
- »
- Antibiotics
Antibiotics
Erythromycin Stearate Tablets BP
Brand | ERYSTY 500 |
Dosage Form | Tablet |
Dose/Strength | 500mg |
Form | Tablet |
Packaging Type | BLISTER PACK |
Composition | Erythromycin Stearate BP Eq to Erythromycin 500mg |
Manufacturer | DEVLIFE CORPORATION PVT. LTD.\ |
Also gives | Third Party Manufacturing |
Treatment | Macrolide Antibiotics |
Shelf life | 3 Years |
Prescription/Non prescription | Prescription |
Strength | 500 mg |
ERYSTY 500
Erythromycin Stearate Tablets BP
COMPOSITION:
Each film coated tablet contains:
Erythromycin stearate BP
Eq. to Erythromycin 500mg
Excipients q.s
Colour: Erythrosine
INDICATION:
Infections due to susceptible micro-organisms such as gram-positive cocci and bacilli. Erythromycin stearate has been found to be effective in vitro against Gram-positive organisms such as Staphylococcus aureus, Streptococcus pyogenes and Streptococcus viridans, enterococci and pneumococci. It also inhibits some strains of Neisseriae, Haemophilus influenzae, Corynebacterium diphtheriae, Listeria, Pasteurella and Treponema.
Upper and lower respiratory tract infections due to Streptococcus pyogenes, Haemophilus influenzae and Mycoplasma pneumoniae.
Erythromycin stearate is an alternate treatment for Neisseria gonorrhoea and primary syphilis in patients allergic to the penicillins. Before treatment of gonorrhoea patients who are suspected of also having syphilis should have a microscopic examination for T. pallidum.
Erythromycin is successful as adjunctive therapy to the antitoxin in the treatment of tetanus. The drug has also proved to be successful in the treatment of infections due to Bordetella pertussis and Listeria monocytogenes.
PRESENTATION : 10 X 10 TABLETS IN CARTON WITH PACK INSERT
Specification :
Used for ;
Upper respiratory tract infections
Adjunctive therapy to the antitoxin in the treatment of tetanus
Infection Due to Bordetella pertussis & Listeriosis monocytogenes.
Skin and skin structure infections
Diphtheria
Additional Information:
- Item Code: T018
- Packaging Details: 10 x 10 BLISTER IN PRINTED CARTON WITH PACK INSERT
Ceftriaxone & Sulbactam for Injection
Brand Name | DEVAXSAL |
Strength | 1.5 gm |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Injection Site | IV or IM |
Form | Powder |
Packaging Type | Vial |
Additional Information:
- Packaging Details: 20ml Vial with 10 ml WFI in printed carton.
Cefalexin Capsules BP 250 Mg
Packaging size | PVC BLISTER,AVAILABLE IN PACK OF 1000,500,100 |
Brand | CEFAXIN |
Composition | Cefalexin Monohydrate BP Eq to Anhydrous Cefalexin 250mg Excipients q.s |
Manufacturer | DEV LIFE CORPORATION |
Prescription/Non prescription | Prescription |
Grade Standard | Medicine Grade |
Color | APPROVED COLORS USED IN EMPTY CAPSULES SHELLS |
Quantity Per Pack | 1000,500,100 |
Medicine Type | Allopathic |
Packaging Type | Strips |
Product Type | Finished Product |
Strength | 250mg |
Form | CAPSULE |
Composition:
Each hard gelatin capsule contains:
Cefalexin Monohydrate BP Eq. to Anhydrous Cefalexin……250mg
Excipients…………………………………..............................................………q.s
Approved colour used in empty capsule shell.
Indications:
Cefalexin is indicated in the treatment of Respiratory Infections, Otitis Media, Skin and Soft tissue infections, bone and joint infections, genito-urinary infections including acute prostatitis and dental infections
Presentation: 100 X 10, 10 X 50, 10 X 10
Additional Information:
- Item Code: CAP004
- Packaging Details: 100 X 10, 50 X 10, 10 X 10 CAPSULES IN PRINTED CARTON WITH PACK INSERT
Cefalexin Capsules BP 500 Mg
Packaging size | AVAILABLE IN PACK OF 1000 500 100 |
Brand | CEFAXIN |
Composition | Cefalexin Monohydrate BP Eq to Anhydrous Cefalexin 500mg Excipients q.s |
Manufacturer | DEV LIFE CORPORATION |
Prescription/Non prescription | Prescription |
Type Of Medicines | Allopathic |
Grade Standard | Medicine Grade |
Color | APPROVED COLORS USED IN EMPTY CAPSULES SHELLS |
Medicine Type | Allopathic |
Packaging Type | Strips |
Product Type | Finished Product |
Strength | 500mg |
Form | CAPSULE |
CEFAXIN
Cefalexin Capsules BP 250 mg and 500 mg
Composition:
Each hard gelatin capsule contains:
Cefalexin Monohydrate BP Eq. to Anhydrous Cefalexin……500mg
Excipients………………………………………...............................................…q.s
Approved colour used in empty capsule shell.
Indications:
Cefalexin is indicated in the treatment of Respiratory Infections, Otitis Media, Skin and Soft tissue infections, bone and joint infections, genito-urinary infections including acute prostatitis and dental infections
Presentation: 100x10 & 10x50 Capsules in printed carton with pack insert.
Additional Information:
- Item Code: CAP005
- Packaging Details: PVC BLISTER, AVAILABLE IN PACK OF 1000, 500 & 100
Azithromycin Tablets 250mg (THROAX 250)
Brand | THROAX 250 |
Dosage | 250 mg |
Tablets in a Strip | 6 |
Form | Tablet |
Composition | Azithromycin dihydrate 250 mg |
Manufacturer Name | DEVLIFE CORPORATION PVT. LTD. |
Deals in | Third Party Pharma |
Packaging Type | Alu-Alu |
Prescription Required | Prescription |
Shelf life | 3 Years |
Country of Origin | Made in India |
Each film coated tablet contains :
Azithromycin dihydrate Eq. to Azithromycin USP
(Anhydrous) .................. 250 mg
Excipients ............................. q.s.
INDICATIONS:
Azithromycin Tablets are indicated in the treatment of the following infections
Acute Bacterial Sinusitis, Acute Bacterial Otitis Media, Pharyngitis, Tonsillitis, Acute exacerabation of Chronic Bronchitis, Mild to moderately severe community acquired pneumonia, skin and soft tissue infections, uncomplicated Chlamydia trachomatis urethritis and cervicitis
DOSAGE & ADMINISTRATION:
Adults and Elderly
For uncomplicated Chlamydia Trachomatis urethritis and cervicitis: 1000 mg as a single oral dose
For all other indications: 1500 mg; to be administered as 500 mg per day for three consecutive days
Pediatric Population
Azithromycin tablets should only be administered to children weighing more than 45 kg when normal adult dose should be used. For children under 45 kg other pharmaceutical forms of azithromycine, e.g. suspensions, may be used.
Specification : Indicated for ;
- Acute Bacterial Sinusitis
- Acute Bacterial Otitis Media
- Pharyngitis
- Tonsillitis
- Acute exacerbation of Chronic Bronchitis
- Mild to moderately severe community acquired pneumonia
- skin and soft tissue infections
- uncomplicated Chlamydia trachomatis urethritis and cervicitis
Additional Information:
- Packaging Details: 1 x 6 Tablets in printed carton with pack insert.
Azithromycin 500 mg Tablets THROAX
Brand | THROAX, THROAX 500 |
Dosage | 500 mg |
Tablets in a Strip | 3 |
Form | Tablet |
Composition | Azithromycin dihydrate Eq. to Azithromycin USP (Anhydrous) 500 mg |
Manufacturer Name | DEVLIFE CORPORATION PVT. LTD. |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Packaging Type | Alu-Alu |
Deals in | Third Party Pharma |
Prescription Required | Prescription |
Shelf life | 3 Years |
Country of Origin | Made in India |
Each film coated tablet contains :
Azithromycin dihydrate Eq. to Azithromycin USP
(Anhydrous) .................. 500 mg
Excipients .................................. q.s.
INDICATIONS:
Azithromycin Tablets are indicated in the treatment of the following infections
Acute Bacterial Sinusitis, Acute Bacterial Otitis Media, Pharyngitis, Tonsillitis, Acute exacerabation of Chronic Bronchitis, Mild to moderately severe community acquired pneumonia, skin and soft tissue infections, uncomplicated Chlamydia trachomatis urethritis and cervicitis
DOSAGE & ADMINISTRATION:
Adults and Elderly
For uncomplicated Chlamydia Trachomatis urethritis and cervicitis: 1000 mg as a single oral dose
For all other indications: 1500 mg; to be administered as 500 mg per day for three consecutive days
Pediatric Population
Azithromycin tablets should only be administered to children weighing more than 45 kg when normal adult dose should be used. For children under 45 kg other pharmaceutical forms of azithromycine, e.g. suspensions, may be used.
Specification :
Indicated for ;
- Acute Bacterial Sinusitis
- Acute Bacterial Otitis Media
- Pharyngitis
- Tonsillitis
- Acute exacerbation of Chronic Bronchitis
- Mild to moderately severe community acquired pneumonia
- skin and soft tissue infections
- uncomplicated Chlamydia trachomatis urethritis and cervicitis
Additional Information:
- Packaging Details: 1 x 3 Tablets in printed carton with pack insert.
Ciprofloxacin Tablets USP 750 Mg
Packaging Type | Alu-Alu |
Packaging Size | 10x1x10 |
Dosage | As directed by the Physician. |
Brand Name | Cipflacin 750 |
Composition | Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 750mg |
Usage/Application | Bacterial Infection |
Form | Tablets |
Also Gives | Third Party Manufacturing |
Type Of Medicines | Allopathic |
Treatment | Quinolone Antibiotics |
Shelf Life | 3 Years |
CIPFLACIN 750
COMPOSITION:
Each film coated tablet contains:
Ciprofloxacin Hydrochloride USP
Eq. to Ciprofloxacin 750mg
Excipients q.s
Colour: Titanium Dioxide
Specification : Used in ;
- Urinary Tract Infections
- Acute Uncomplicated Cystitis in females
- Chronic Bacterial Prostatitis
- Lower Respiratory Tract Infections
- Acute Sinusitis
- Skin and Skin Structure Infections
- Bone and Joint Infections
- Complicated Intra-Abdominal Infections
- Infectious Diarrhea
- Typhoid Fever (Enteric Fever)
- Uncomplicated cervical and urethral gonorrhoea
Additional Information:
- Item Code: T012
- Packaging Details: 10 x 1 x 10 Tablets in Alu Alu Blister in Printed Carton with Pack Insert.
Ciprofloxacin Tablets USP 500 Mg
Brand Name | CIPFLACIN |
Strength | 500 mg |
Form | Tablet |
Composition | Each film coated tablet contains Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 500mg |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Also gives | Third Party Manufacturing |
Shelf life | 3 Years |
Prescription/Non prescription | Prescription |
Country of Origin | Made in India |
CIPFLACIN
COMPOSITION:
Each film coated tablet contains:
Ciprofloxacin Hydrochloride USP
Eq. to Ciprofloxacin 500mg
Excipients q.s
Colour: Titanium Dioxide
INDICATIONS:
Ciprofloxacin Tablets is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below
1. Urinary Tract Infections
2. Acute Uncomplicated Cystitis in females
3. Chronic Bacterial Prostatitis
4. Lower Respiratory Tract Infections
5. Acute Sinusitis
6. Skin and Skin Structure Infections
7. Bone and Joint Infections
8. Complicated Intra-Abdominal Infections
9. Infectious Diarrhea
10. Typhoid Fever (Enteric Fever)
11. Uncomplicated cervical and urethral gonorrhoea
Specification : Used in ;
- Urinary Tract Infections
- Acute Uncomplicated Cystitis in females
- Chronic Bacterial Prostatitis
- Lower Respiratory Tract Infections
- Acute Sinusitis
- Skin and Skin Structure Infections
- Bone and Joint Infections
- Complicated Intra-Abdominal Infections
- Infectious Diarrhea
- Typhoid Fever (Enteric Fever)
- Uncomplicated cervical and urethral gonorrhoea
Additional Information:
- Packaging Details: 10 x 1 x 10 Tablets in Printed carton with Pack insert.
Ciprofloxacin Tablets USP 500 mg
Strength | 500mg |
Packaging Size | 1 x 10 Tablets |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Brand Name | CIPFLACIN |
Composition | Each film coated tablet contains: |
Treatment | Quinolone Antibiotic |
Prescription/Non prescription | Prescription |
Form | Tablet |
Also Gives | Third Party Manufacturing |
Shelf life | 3 Years |
Country of Origin | Made in India |
Each film coated tablet contains:
Ciprofloxacin Hydrochloride USP
Eq. to Ciprofloxacin 500mg
Excipients q.s
Colour: Titanium Dioxide
INDICATIONS:
Ciprofloxacin Tablets is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below
1. Urinary Tract Infections
2. Acute Uncomplicated Cystitis in females
3. Chronic Bacterial Prostatitis
4. Lower Respiratory Tract Infections
5. Acute Sinusitis
6. Skin and Skin Structure Infections
7. Bone and Joint Infections
8. Complicated Intra-Abdominal Infections
9. Infectious Diarrhea
10. Typhoid Fever (Enteric Fever)
11. Uncomplicated cervical and urethral gonorrhoea
Additional Information:
- Packaging Details: 1x10 Tablets in printed carton wit pack insert.
Ciprofloxacin Hydrochloride USP
Brand Name | CIPFLACIN |
Strength | 500 mg |
Form | Tablets |
Also gives | Third Party Manufacturing |
Packaging Type | Blister |
Composition | Each film coated tablet contains: |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Prescription/Non prescription | Prescription |
Country of Origin | Made in India |
Composition:
Each film coated tablet contains:
Ciprofloxacin hydrochloride USP 582.21mg eq to
Ciprofloxacin …………500 mg
Excipients Q.S
Colour: Titanium dioxide
Indications:
CIPFLACIN contains the active substance ciprofloxacin. Ciprofloxacin is an belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria.
CIPFLACIN is used in adults to treat the following bacterial infections:
·respiratory tract infections long lasting or recurring ear or sinus infections
· urinary tract infections
· genital tract infections in men and women
· gastro-intestinal tract infections and intra-abdominal infections
· skin and soft tissue infections
· bone and joint infections
· to prevent infections due to the bacterium Neisseria meningitidis
· anthrax inhalation exposure
· anthrax inhalation exposure
Presentation: 10 x 10 Tablets in Monocarton
Additional Information:
- Packaging Details: 10 x 10 Tablets in Printed carton with pack insert.
Metronidazole 250mg Tablets
Packaging Size | 10 x 10 tablets |
Manufacturer | DEV LIFE CORPORATION |
Prescription/Non prescription | Prescription |
Dosage | As directed by the Physician. |
Packaging Type | Strips |
Brand | Dev Life Corporation |
Composition:
Each tablet contains:
Metronidazole BP...................250 mg
Excipients...................................q.s
Colour : Titanium Dioxide BP
Indication:
The prevention of postoperative infections due to anaerobic bacteria, particularly
species of Bacteroides and anaerobic Streptococci.
-- The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising
pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and postoperative
wound infections from which pathogenic anaerobes have been isolated.
Metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic
bacteria have been identified or are suspected to be the cause.
Metronidazole is active against a wide range of pathogenic micro-organisms notably species
of Bacteroides, Fusobacteria, Clostridia, Eubacteria, anaerobic cocci and Gardnerella
vaginalis. It is also active against Trichomonas, Entamoeba histolytica, Giardia lamblia
and Balantidium coli.
The prevention of post-operative infections due to anaerobic bacteria, particularly
species of Bacteroides and anaerobic streptococci.
2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising
pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and postoperative
wound infections from which pathogenic anaerobes have been isolated.
3. Urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male.
4. Bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or
Gardnerella vaginitis).
Presentation: 10 x 10 Tab
Metronidazole Oral Suspension BP
Manufacturer | DEVLIFE CORPORAION PVT. LTD. |
Brand | Devmet |
Pack size | 100 ML |
Prescription/Non prescription | Prescription |
Treatment | Antibiotics (Nitroimidazole) |
Composition | Metronidazole Benzoate BP eq to Metronidazole 125mg |
Shelf life | 3 Years |
Form | ORAL SUSPENSION |
Strength | 125 mg/5ml |
DEVMET
Metronidazole Oral suspension BP
COMPOSITION:
Each 5ml contains:
Metronidazole Benzoate BP
Eq to Metronidazole ……........125mg
Flavoured Syrupy Base …………….. q.s
Colour: Tartrazine
INDICATION:
Metronidazole is indicated in adults and children for the following indications:
In the treatment of urogenital trichomonaisis.
In the treatment of acute ulcerative gingivitis.
In the treatment of infections due to E. histolytica
In the treatment of infections due to G. Lamblia
In the prevention and treatment of infections due to anaerobic bacteria, particularly species of Bacteroides, anaerobic Streptococci, fusobacteria, clostridia, etc.
In the treatment of acute dental infections.
In the treatment of non-specific vaginitis.
Metronidazole is indicated in adults only for the following indications:
In the treatment of chronic pressure sores and ulcers with possible infection due to anaerobes.
Consideration should be given to official guidance on the appropriate use of antibacterial agents
Specification :
In the treatment of urogenital trichomonaisis.
In the treatment of acute ulcerative gingivitis.
In the treatment of infections due to E. histolytica
In the treatment of infections due to G. Lamblia
In the prevention and treatment of infections due to anaerobic bacteria, particularly species of Bacteroides, anaerobic Streptococci, fusobacteria, clostridia, etc.
In the treatment of acute dental infections.
In the treatment of non-specific vaginitis.
Additional Information:
- Item Code: L007
- Packaging Details: 100 ML IN PET BOTTLE WITH CARTON & PACK INSERT
Devgentam Gentamicin Injection BP 10 mg/ml
Brand Name | DEVGENTAM |
Strength | 10mg/ml |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Injection Site | IV or IM |
Form | Solution |
Packaging Type | Vial |
Composition | Each ml contains : |
INDICATION :To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Injection and other antibacterial drugs, Gentamicin Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria Gentamicin Injection is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: Pseudomonas aeruginosa, Proteus species, Escherichia coli, Klebsiella-Enterobacter-Serratia species, Citrobacter species, and Staphylococcus species.Gentamicin Injection may be considered as initial therapy in suspected or confirmed gram-negative infections, and therapy may be instituted before obtaining results of susceptibility testing. If the causative organisms are resistant to Gentamicin Injection, other appropriate therapy should be instituted.Gentamicin Injection has been used effectively in combination with carbenicillin for the treatment of life-threatening infections caused by Pseudomonas aeruginosa. It has also been found effective when used in conjunction with a penicillin-type drug for the treatment of endocarditis caused by group D streptococci.Gentamicin Injection has also been shown to be effective in the treatment of serious staphylococcal infections.
DOSAGE AND ADMINISTRATION :Dosage For Patients With Normal Renal FunctionChildren : 6 to 7.5 mg / kg / day. Infants and Neonates: 7.5 mg / kg / day. Premature or Full-term Neonates One Week of Age or Less : 5mg /kg / dayIt is desirable to measure periodically both peak and through serum concentrations of Gentamicin Injection when feasible during therapy to assure adequate but not excessive drug levels. For example, the peak concentration is expected to be in the range of 3 to 5 mcg/mLFor Intravenous AdministrationThe intravenous administration of Gentamicin Injection may be particularly useful for treating patients with bacterial septicemia or those in shock. It may also be the preferred route of administration for some patients with congestive heart failure, hematologic disorders, severe burns, or those with reduced muscle mass.Dosage For Patients With Impaired Renal FunctionDosage must be adjusted in patients with impaired renal function to assure therapeutically adequate but not excessive, blood levels. Whenever possible, serum concentrations of Gentamicin Injection should be monitored. In adults, the interval between doses (in hours) may be approximated by multiplying the serum creatinine level by 8.
Additional Information:
- Packaging Details: 10 x 2 ml Ampoules in printed carton with pack insert.
Flucloxacillin Capsule BP - Flucin 250
Pack size | 10 x 10 |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Composition | Flucloxacillin Sodium BP eq to Flucloxacillin 250mg Excipients q. |
Also gives | Third Party Manufacturing |
Packaging Type | 10 x 10 Alu Alu Blister |
Brand | FLUCIN 250 |
Strength (mg) | 250 mg |
FLUCLOXACLLIN CAPSULES BP
FLUCIN 250
COMPOSITION:
Each hard gelatin capsule contains:
Flucloxacillin Sodium BP eq to Flucloxacillin......250mg
Excipients................................................................qs
Approved colour used in empty capsule shell
INDICATION:
Infections caused by susceptible organisms, including:
Skin and soft tissue infections: Orthopaedic infections
Infected wounds and burns: Septicaemia
Otitis media: Meningitis
Urinary tract infections: Endocarditis
Respiratory tract infections caused by penicillinase-producing organisms: Enterocolitis
Additional Information:
- Packaging Details: 10x10 Capsules in printed carton with pack insert.
Glucose Intravenous Infusion BP 500ml
Packaging Size | 500ml |
Usage/Application | Hospital |
Brand | DLC-DEXTROSE |
Composition | Glucose Anhydre |
Shelf Life | 36 months |
Glucose Anhydrous B.P. ......... 5.0g
Water for Injections B.P. ......... q.s.
Additional Information:
- Packaging Details: 500 ml IV with euro cap
Glucose Intravenous Infusion BP 100ml
Packaging Size | 500ml |
Usage/Application | Hospital |
Brand | DLC-DEXTROSE DS |
Composition | Glucose Anhydre |
Shelf Life | 36 months |
Country of Origin | Made in India |
Glucose Anhydrous B.P. ........ 10g
Water for Injection B.P. ........ q.s.
Additional Information:
- Packaging Details: 500ml with Euro cap
Gentamicin Sulphate Injection
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Injection Site | IV or IM |
Form | Solution |
Packaging Type | Box |
Country of Origin | Made in India |
Dosage | As directed by the Physician. |
Gentamicin Sulphate Injection indicates for:
- To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Injection, USP and other antibacterial drugs, Gentamicin Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Additional Information:
- Packaging Details: 5x5ml Ampoules in printed carton with pack insert.
Cefotaxime Sodium 1000mg Injection USP
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Pack size | 10 Vials without Diluent in Printed Carton |
Composition | Each vial contains Cefotaxime Sodium USP eq to Cefotaxime................. 1g |
Medicine Type | Injection |
Product Type | Finished Product |
Shelf life | 24 MONTHS |
Form | Injection |
Cefotaxime Sodium 1000mg Injection USP
Composition:
Each vial contains:
Cefotaxime Sodium USP eq to Cefotaxime................. 1g
Indication:
Cefotaxime is an antibiotic. It belongs to a group of antibiotics that are called cephalosporins. These types of antibiotic are similar to
penicillin.
Cefotaxime kills bacteria and it can be used to treat infections of the:
• Kidneys and bladder
• Blood
• Skin and flesh immediately under the skin
• Bones
• Heart valves
• Brain
• Abdomen
• Some sexually transmitted infections (gonorrhoea)
It can also be used to prevent and treat infections following surgical operations.
Presentation: 10 Vials without diluent in Printed Carton
Additional Information:
- Item Code: INJ003
- Packaging Details: 10 Vials without Diluent in Printed Carton with pack insert.
Azithromycin 500 mg Capsules
Packaging Size | 1 X 3 Capsules |
Brand | THROAX |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Composition | Azithromycin USP (As Dihydrate) |
Prescription/Non prescription | Prescription |
Deals in | Third Party Manufacturing |
Form | Capsules |
Country of Origin | Made in India |
Each hard gelatin capsule contains:
Azithromycin USP (As Dihydrate)
Eq. to Azithromycin (Anhydrous) .... 500 mg
Excipients ........................................... q.s.
Approved colour used in capsule shell.
INDICATIONS:
Azithromycin Capsules are indicated in the treatment of the following infections:
Acute Bacterial Sinusitis, Acute Bacterial Otitis Media, Pharyngitis, Tonsillitis, Acute exacerabation of Chronic Bronchitis, Mild to moderately severe community acquired pneumonia, skin and soft tissue infections, uncomplicated Chlamydia trachomatis urethritis and cervicitis
DOSAGE & ADMINISTRATION:
Adults and Elderly
For uncomplicated Chlamydia Trachomatis urethritis and cervicitis: 1000 mg as a single oral dose
For all other indications: 1500 mg; to be administered as 500 mg per day for three consecutive days
Pediatric Population
Azithromycin capsules should only be administered to children weighing more than 45 kg when normal adult dose should be used. For children under 45 kg other pharmaceutical forms of azithromycin, e.g. suspensions, may be used.
Additional Information:
- Packaging Details: 1x3 Capsules in printed carton with pack insert.
Flucloxacillin Oral Solution BP
Brand | FLUCIN S250 |
Usage/Application | Commercial |
Dose | As directed by the Physician. |
Packaging Size | 100 ml |
Also Gives | Third Party Manufacturing |
Medicine Type | Allopathic |
Packaging Type | HDPE Bottle |
Product Type | ORAL SUSPENSION |
Shelf Life | 2 Years |
Treatment | Beta lactam Antibiotic |
Flucloxacillin Sodium BP
Eq. to Flucloxacillin ....... 250 mg
Excipients .......................... q.s.
Color : Sunset Yellow FCF
Indication:
Flucloxacillin Oral Solution is an antibiotic used to treat infections by killing the bacteria that can cause them. It belongs to a group of antibiotics called “penicillins”. Flucloxacillin Oral Solution is used to treat: • chest infections• throat or nose infections• ear infections• skin and soft tissue infections• heart infections• bones and joints infection• meningitis• digestive system infections• blood infections• kidney, bladder or the urethra (the tube which carries urine from the bladder) infections.Flucloxacillin Oral Solution can also be used to prevent infections during major surgery, particularly heart or orthopaedic surgery
Dosage and Administration:•Adults and children over 10 years: 10ml four times a day. •Joint infections (osteomyelitis) or heart infections (endocarditis) - up to 8g daily in divided doses, six to eighthourly. •To prevent infection due to surgery - 1 to 2g by injection into a vein, at the same time as the anaesthetic, followed by 500mg six hourly either by mouth or injection into a vein or muscle for up to 72 hours. •Children 2 to 10 years: one 5ml spoonful four times a day. •Children under 2 years: 2.5 ml four times a day, your pharmacist will explain how to give this to your child. •Premature or babies less than 4 weeks old – Not recommended. •Severe kidney disease: your doctor may reduce the dose, maximum dose in adults is 1g every 8-12 hours.
Specification : used to treat:
· chest infections
· throat or nose infections
· ear infections
· skin and soft tissue infections
· heart infections
· bones and joints infection
· meningitis
· digestive system infections
· blood infections
· kidney, bladder or the urethra (the tube which carries urine from the bladder) infections
Additional Information:
- Packaging Details: 100 ml Bottle In printed carton with pack insert.
Flucloxacillin Injection BP
Dose / Strength | 500 mg |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Brand | FLUCIN I 500 |
Prescription/Non prescription | Prescription |
Composition | Flucloxacillin |
Packaging Size | 500 mg |
Medicine Type | Allopathic |
Also Gives | Third Party Manufacturing |
Form | Injection |
Each Vial contains:
Flucloxacillin Sodium BP
Eq. to Flucloxaciilin ............ 500 mg
Indication:
- Flucloxacillin is indicated for the treatment of infections due to Gram-positive organisms, including infections caused by ß-lactamase-producing staphylococci and streptococci. Typical indications include:
- Skin and soft tissue infections: boils, abscesses, carbuncles, furunculosis, cellulitis; infected skin conditions, e.g. ulcer, eczema and acne; infected wounds, infected burns, protection for skin grafts and impetigo.
- Respiratory tract infections: pneumonia, lung abscess, empyema, sinusitis, pharyngitis, tonsillitis, quinsy, otitis media and externa.
- Other infections caused by flucloxacillin-sensitive organisms: osteomyelitis, enteritis, endocarditis, urinary tract infection, meningitis, septicaemia.
- Flucloxacillin is also indicated for use as a prophylactic agent during major surgical procedures where appropriate: for example, cardiothoracic and orthopaedics
Presentation:
- 500 mg vial
Additional Information:
- Packaging Details: 10 Vials in printed carton with pack insert.
Flucloxacllin Capsules Bp 500mg
Strength | 500mg |
Packaging size | 10 X 10 |
Brand | FLUCIN 500 |
Composition | COMPOSITION Each hard gelatin capsule contains Flucloxacillin Sodium BP eq to Flucloxacillin ..... |
Manufacturer | DEV LIFE CORPORATION |
Form | CAPSULE |
Shelf life | 36 MONTHS |
Color | APPROVED COLORS USED IN EMPTY CAPSULE SHELL |
Packaging Type | Strips |
FLUCLOXACLLIN CAPSULES BP
FLUCIN 500
COMPOSITION:
Each hard gelatin capsule contains:
Flucloxacillin Sodium BP eq to Flucloxacillin ...... 500mg
Excipients ...................................................................... qs
Approved colour used in empty capsule shell
INDICATION:
Infections caused by susceptible organisms, including:
Skin and soft tissue infections: Orthopaedic infections
Infected wounds and burns: Septicaemia
Otitis media: Meningitis
Urinary tract infections: Endocarditis
Respiratory tract infections caused by penicillinase-producing organisms: Enterocolitis
Additional Information:
- Item Code: CAP007
- Packaging Details: 10 X 10 BLISTER IN CARTON WITH PACK INSERT
Ciprofloxacin 250 mg Suspension
Packaging Size | 100 ml bottle in printed carton with pack insert |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Composition | Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 250 mg |
Prescription/Non prescription | Prescription |
Treatment | ANTIBIOTIC |
Dosage Form | ORAL SUSPENSION |
Usage/Application | Commercial |
Dose | As directed by the Physician. |
Category | Antibiotic |
Form | SUSPENSION |
Shelf life | 3 Years |
Brand | CIPFLACIN 250 |
CIPFLACIN 250
Ciprofloxacin 250 mg Suspension
COMPOSITION:
Each 5 ml contains:
Ciprofloxacin Hydrochloride USP
Eq. to Ciprofloxacin .......... 250 mg
Excipients ............................... q.s.
INDICATION:
CIPFLACIN oral suspension is indicated for the treatment of the following infections.
respiratory tract infections, long lasting or recurring ear or sinus infections, urinary tract infections, genital tract infections in men and women, gastro-intestinal tract infections and intra-abdominal infections, skin and soft tissue infections, bone and joint infections, to prevent infections due to the bacterium Neisseria meningitidis, anthrax inhalation exposure.
Ciprofloxacin may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection.
Specification:
Used in the treatment of;
Respiratory Tract Infections
Recurring Ear or Sinus Infections
Urinary Tract Infections
Genital Tract Infections
Gastro-Intestinal Tract Infections
Intra-Abdominal Infections
Skin and Soft Tissue Infections
Bone and Joint Infections
Management of Patients with Low White Blood Cell Counts who have a fever that is suspected to be due to bacterial infections.
Additional Information:
- Packaging Details: 100 ml bottle in printed carton with pack insert
METROLINA Metronidazole Intravenous Infusion BP
Packaging Size | 100ml |
Usage/Application | Hospital |
Brand | METROLINA |
Composition | Metronidazole |
Usage | Clinical |
Country of Origin | Made in India |
Composition :
Each 100 ml contains:
Metronidazole BP.................500mg
Water for Injection BP................q.s
INDICATIONS AND USAGE
It is used for :
Treatment of Anaerobic Infections
Intra-abdominal Infections
Skin and Skin Structure Infections
Gynecologic Infections
Bacterial Septicemia
Bone and Joint Infections,
Central Nervous System (CNS) Infections,
Lower Respiratory Tract Infections
Endocarditis
Presentation :
100 ml in Single Dose Container, Flexible Container.
Additional Information:
- Packaging Details: 100 ml Bottle in printed carton with pack insert.
Azithromycin For Oral Suspension USP 200mg/5ml
Packaging Size | 15 ml |
Composition | Azithromycin (as Dihydrate) USP Eq. to Azithromycin base 200mg |
Manufactured By | DEVLIFE CORPORATION PVT. LTD. |
Usage/Application | Commercial |
Product Type | Finished Product |
Dose | As directed by the Physician |
Brand | DEVAZY |
Form | ORAL SUSPENSION |
Strength | 200mg / 5ml |
Shelf Life | 3 Years |
Treatment | Macrolide Antibiotics |
Each 5ml of reconstituted suspension contains:
Azithromycin (as Dihydrate) USP
Eq. to Azithromycin base ………. 200mg
Excipients …………………………… q.s.
Colour: Tatrazine
INDICATION:
Azithromycin powder for oral suspension is indicated for the treatment of the following infections, when caused by microorganisms sensitive to azithromycin.
- acute bacterial sinusitis (adequately diagnosed)
- acute bacterial otitis media (adequately diagnosed)
- pharyngitis, tonsillitis
- acute exacerbation of chronic bronchitis (adequately diagnosed)
- mild to moderately severe community acquired pneumonia
- skin and soft tissue infections
Specification :
Treatment of the following infections, when caused by microorganisms sensitive to azithromycin.
- acute bacterial sinusitis (adequately diagnosed)
- acute bacterial otitis media (adequately diagnosed)
- pharyngitis, tonsillitis
- acute exacerbation of chronic bronchitis (adequately diagnosed)
- mild to moderately severe community acquired pneumonia
- skin and soft tissue infections
Additional Information:
- Packaging Details: 15 ml Bottle in printed carton with pack insert.
Cefuroxime Axetile Tablets USP 250mg
Brand Name | DEVOXIME |
Strength | 250mg |
Pharmacopoeia Status | USP |
Also gives | Third Party Manufacturing |
Storage Type | STORE IN COOL & DRY PLACE,PROTECT FROM LIGHT |
Form | Tablet |
Packaging Size | 100 TABLETS |
Composition | Each film coated tablet contains: |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Prescription/Non prescription | Prescription |
Country of Origin | Made in India |
DEVOXIME
Cefuroxime Axetile Tablets USP 250mg (and 125mg)
COMPOSITION:
Each film coated tablet contains:
Cefuroxime Axetile USP
Eq. to Cefuroxime …….250mg
Excipients……………..........qs
Colour: Titanium Dioxide BP
INDICATION:
is used to treat infections of:
Throat
Sinus
Middle ear
Lungs or chest
Urinary Tract
Skin and soft tissues.
can also be used to treat Lyme disease (an infection spread by parasites calledticks).
PRESENTATION:
10 X 10 Tablets in Printed Carton with Pack Insert
Additional Information:
- Item Code: T017
- Packaging Details: 10 x 10 TABLETS IN ALU ALU BLISTER IN PRINTED CARTON WITH PACK INSERT
Levofloxacin Tablets USP
Packaging Size | 500 mg |
Brand | DEFLOX |
Manufacturer | DEV LIFE CORPORATION |
Composition | Each film coated tablet contains: |
Prescription/Non prescription | Prescription |
Form | Tablet |
Each film coated tablet contains:
Levofloxacin Hemihydrate USP
Eq. to Levofloxacin .............. 500 mg
Excipients ......................................... q.s.
Colour: Red Oxide of Iron & Titanium Dioxide USP
INDICATION:
Levofloxacin Tablets is indicated in adults for the treatment of the following infections.
• Acute bacterial sinusitis.
• Acute exacerbations of chronic bronchitis.
• Community-acquired pneumonia.
• Complicated skin and soft tissue infections
DOSAGE AND ADMINISTRATION:
Levofloxacin Tablets are administered once or twice daily. The dosage depends on the type and severity of the infection and the sensitivity of the presumed causative pathogen.
The recommended dose is 500mg-1000mg max for a maximum period of upto 10-14 days.
Additional Information:
- Packaging Details: 1 x 10 Tablets in printed carton with pack insert.
Clincin Clindamycin Injection Usp
Brand | CLINCIN |
Manufacturer | DEV LIFE CORPORATION |
Composition | Each ml contains: |
Prescription/Non prescription | Prescription |
Usage/Application | Commercial |
Injectable Form | Liquid |
Dose | As directed by the Physician. |
Packaging Size | 5 x 2ml |
Medicine Type | Allopathic |
Composition :
Each ml contains :
Clindamycin Phosphate USP eq to Clindamycin ........150 mg
Benzyl Alcohol BP (as Preservative )................................ 9 mg
Water for Injection USP ....................................................q.s.
Indications :
Clindamycin Injection is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin Injection is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved
for -allergic patients or other patients for whom, in the judgment of the physician, a is inappropriate. Clindamycin Injection is indicated in the treatment of serious
infections caused by susceptible strains of the designated organisms in the conditions listed below :
Lower respiratory tract infections including pneumonia, empyema, and lung abscess caused by anaerobes, Streptococcus pneumoniae, other streptococci, and Staphylococcus aureus.
Skin and skin structure infections caused by Streptococcus pyogenes, Staphylococcus aureus, and anaerobes. Gynecological infect ions including endomet r i t is, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.
Intra-abdominal infections including peritonitis and intraabdominal abscess caused by susceptible anaerobic organisms.
Presentation : 2 ml Ampoule
Azithromycin for Oral Suspension USP
Packaging Size | 15 ml |
Manufactured By | DEVLIFE CORPORATION PVT. LTD. |
Usage/Application | Commercial |
Product Type | Finished Product |
Dose | As directed by the Physician |
Brand | THROAX DS |
Form | Suspension |
Treatment | ANTIBIOTICS |
Shelf Life | 2 Years |
Each 5ml of reconstituted suspension contains:
Azithromycin (as dihydrate) USP
Eq. to Azithromycin base ........ 200mg
Excipients ................................. q.s.
Colour: Tartrazine
INDICATIONS :
Azithromycin powder for oral suspension is indicated for the treatment of the following infections.
-Acute bacterial sinusitis (adequately diagnosed)
-Acute bacterial otitis media (adequately diagnosed)
-Pharyngitis, tonsillitis
-Acute exacerbation of chronic bronchitis (adequately diagnosed)
-Mild to moderately severe community acquired pneumonia
-Skin and soft tissue infections
-Uncomplicated Chlamydia trachomatis urethritis and cervicitis.
Considerations should be given to official guidance on the appropriate use of antibacterial agents.
DOSAGE AND ADMINISTRATION :
The total dosage in children aged 1 year and older is 30 mg/kg administered as 10 mg/kg once daily for three days, or over a period of five days starting with a single dose of 10 mg/kg on the first day, followed by doses of 5 mg/kg per day for the following 4 days or as directed by the physician.
Specification : Treatment of the following infections,
- Acute bacterial sinusitis (adequately diagnosed)
- Acute bacterial otitis media (adequately diagnosed)
- Pharyngitis, tonsillitis
- Acute exacerbation of chronic bronchitis (adequately diagnosed)
- Mild to moderately severe community acquired pneumonia
- Skin and soft tissue infections
- Uncomplicated Chlamydia trachomatis urethritis and cervicitis.
Additional Information:
- Packaging Details: 15 ml Bottle in printed carton with pack insert.
Clindamycin Injection
Pack size | 10 X 4ml Ampoules in printed carton with pack insert |
Manufacturer | DEV LIFE CORPORATION |
Composition | Each ampoule contains Clindamycin Phosphate USP Clindamycin equivalent ............................ |
Injectable Form | Liquid |
Packaging Size | 10 X 4ml Ampoules |
Product Type | Finished Product |
Brand | Dev Life Corporation |
Form | Injection |
Clindamycin Injection USP 150mg/ml
COMPOSITION:
Each ampoule contains:
Clindamycin Phosphate USP
Clindamycin equivalent .................................... 150 mg
Benzyl Alcohol BP (as Preservative) ................ 9 mg
Water for injection q.s.p.
INDICATION:
Antibacterial. Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) and pneumococci. It is also indicated in serious infections caused by susceptible anaerobic pathogens such as Bacteroides spp, Fusobacterium spp, Propionibacterium spp, Peptostreptococcus spp. and microaerophilic streptococci.
Clindamycin does not penetrate the blood/brain barrier in therapeutically effective quantities.
Consideration should be given to official guidance on the appropriate use of antibacterial agents including national and local guidelines
Additional Information:
- Packaging Details: 10x4ml Ampoules
Sulfadiazine 500 mg Tablets USP
Strength | 500 mg |
Packaging Type | Box |
Packaging Size | 10*10 Tablets |
Brand | Devlife Corporation Pvt. Ltd. |
Shelf Life | 36 months |
Usage / Application | Clinical |
Each uncoated tablet contains :
- Sulfadiazine USP ........500mg
- Excipients ..........................q.s.
Indications:
- Sulfadiazine is a short-acting sulfonamide that is used in the treatment of infections due to susceptible organisms. It is used in treatment of nocardiosis and lymphogranuloma venereum, and has been given for the prophylaxis ofrheumatic fever in allergic patients.
Presentation:
- 100 tablets
Additional Information:
- Packaging Details: 10 x 10 Tablets in printed carton with pack insert.
Metronidazole Tablets BP 500mg
Strength | 500mg |
Packaging size | 10 x 10 BLISTER |
Brand | DEVGYL |
Composition | Metronidazole BP 500mg Excipients..qs Colour Titanium Dioxide |
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Form | Tablet |
Shelf life | 36 MONTHS |
DEVGYL
Metronidazole Tablets BP
COMPOSITION:
Each uncoated tablet contains:
Metronidazole BP………500mg
Excipients…………..qs
Colour: Titanium Dioxide BP
INDICATION:
Symptomatic Trichomoniasis
Metronidazole tablets are indicated for the treatment of symptomatic trichomoniasis in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures
Additional Information:
- Item Code: T022
- Packaging Details: 10 x 10 BLISTER IN CARTON WITH PACK INSERT
Cloxacillin Injection
Usage/Application | Hospital |
Dose | 1ml-5ml, 5ml-10ml |
Injectable Form | Solution |
Application | Analgesics and Pain Relief Medicines, Anti Infective & Common Disease Medicines |
Packaging Type | Glass Bottle |
Country of Origin | Made in India |
Each vial contains:
Cloxacillin Sodium Sterile BP
Equivalent to Anhydrous Cloxacillin: 250 mg
Additional Information:
- Packaging Details: 10 Vials in printed carton with pack insert.
Erythyl Erythromycin Succinate Tablets 250 mg
Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
Prescription/Non prescription | Prescription |
Dosage Form | Tablet |
Brand | ERYTHYL |
Form | Tablet |
Country of Origin | Made in India |
Composition :
Each enteric coated tablet contains :
Erythromycin Ethyl Succinate BP
eq. to Erythromycin base ...................................... 250 mg
Excipients .................................................................. q.s.
Colour : Titanium dioxide BP
Indication :
Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial
infections. Erythromycin is known as a macrolide . It works by stopping the growth of bacteria. This
treats or prevents only bacterial infections. It will not work for viral infections.
Susceptible infections including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires' disease,
pertussis, listeriosis.
Presentation : 10 x 10 Tablets in Printed Carton
Additional Information:
- Packaging Details: 10x10 Tablets in printed carton with pack insert.